Int. Journal of Drug cGMP
USA Edition : EU Edition : PR Edition
Locum International Press
Issues #1 - # 8
Eight issues /year
The International Journal of Drug cGMP is
available in three geographic zones (US ; EU and Pacific Rim).
The journal publishes articles, reviews and
papers on all aspects on both Generic and Innovative Drug cGMP issues.
Emphasis is places on current Good Clinical, Development, Validation,
Manufacture, Laboratory, Analytical and Documentation Practices.
The US Journal highlights GMP exposure of the Drug Industry with special
reference to the on-time development of NDA
and ANDA submissions. Similar cGMP concepts
are valid for the EU and Pacific Rim editions.
All aspects of pharmaceutical Good Practices covering practical hands-on
nuts-and-bolts issues that vary across the full manufacturing spectrum,
including drug excipients, formulations and processes, scale-up, analytical,
cleaning and process validation necessary for the entire
drug manufacture and control process to meet the agencies expectations.
The overall objective in cGMP is to maintain the current drug profile
in the market place avoiding warning letters and negative PAI
The Journal attempts to clarify and simplify laboratory, manufacturing
and control GMP, GLP GDP GVP and GRP issues to achieve this crucial objective.
80 - 95 pp illustrated
b/w & color
Subscription - Print
$1499.00 - Print Edition (single-user airmail print edition worldwide)
$1699.00 - Corporate single license single pharma campus - (Print)
$1999.00 - Corporate multiple-user license - (print edition maximizes
distribution and readership for multiple pharma campus).